Using the 2 Stage Free Cash Flow to Equity, OKYO Pharma fair value estimate is US$4.57. OKYO Pharma's US$2.40 share price signals that it might be 47% undervalued. O ...
The Zephyrus Duo. Fit with two 16-inch, 3K, 120 Hz, OLED screens, and one of which sits right where a keyboard usually would.